High Tide Inc.

TSXV:HITI Stock Report

Market Cap: CA$349.3m

High Tide Past Earnings Performance

Past criteria checks 0/6

High Tide's earnings have been declining at an average annual rate of -18.6%, while the Pharmaceuticals industry saw earnings growing at 45.6% annually. Revenues have been growing at an average rate of 45.7% per year.

Key information

-18.6%

Earnings growth rate

25.8%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate45.7%
Return on equity-20.9%
Net Margin-6.0%
Last Earnings Update31 Jul 2024

Recent past performance updates

Recent updates

High Tide Inc.'s (CVE:HITI) Shares Leap 30% Yet They're Still Not Telling The Full Story

Oct 19
High Tide Inc.'s (CVE:HITI) Shares Leap 30% Yet They're Still Not Telling The Full Story

Does High Tide (CVE:HITI) Have A Healthy Balance Sheet?

Oct 04
Does High Tide (CVE:HITI) Have A Healthy Balance Sheet?

Market Cool On High Tide Inc.'s (CVE:HITI) Revenues

Aug 14
Market Cool On High Tide Inc.'s (CVE:HITI) Revenues

Here's What Analysts Are Forecasting For High Tide Inc. (CVE:HITI) After Its Second-Quarter Results

Jun 16
Here's What Analysts Are Forecasting For High Tide Inc. (CVE:HITI) After Its Second-Quarter Results

High Tide (CVE:HITI) Seems To Use Debt Quite Sensibly

Apr 25
High Tide (CVE:HITI) Seems To Use Debt Quite Sensibly

High Tide Inc. (CVE:HITI) Screens Well But There Might Be A Catch

Mar 16
High Tide Inc. (CVE:HITI) Screens Well But There Might Be A Catch

Here's Why High Tide (CVE:HITI) Can Afford Some Debt

Sep 23
Here's Why High Tide (CVE:HITI) Can Afford Some Debt

Take Care Before Diving Into The Deep End On High Tide Inc. (CVE:HITI)

Jul 25
Take Care Before Diving Into The Deep End On High Tide Inc. (CVE:HITI)

Does High Tide (CVE:HITI) Have A Healthy Balance Sheet?

Mar 31
Does High Tide (CVE:HITI) Have A Healthy Balance Sheet?

Is High Tide (CVE:HITI) A Risky Investment?

Nov 16
Is High Tide (CVE:HITI) A Risky Investment?

Revenue & Expenses Breakdown

How High Tide makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSXV:HITI Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jul 24511-30980
30 Apr 24504-34990
31 Jan 24498-36990
31 Oct 23488-391010
31 Jul 23469-621040
30 Apr 23440-611010
31 Jan 23403-68970
31 Oct 22357-72910
31 Jul 22302-22820
30 Apr 22255-21750
31 Jan 22215-25650
31 Oct 21181-34540
31 Jul 21152-32420
30 Apr 21128-27330
31 Jan 21108-19280
31 Oct 2083-6230
31 Jul 2070-20280
30 Apr 2054-28280
31 Jan 2040-26290
31 Oct 1931-26290
31 Jul 1922-15220
30 Apr 1916-12170
31 Jan 1911-9120
31 Oct 189-570
31 Jul 189-150
31 Oct 1710040
31 Oct 168130

Quality Earnings: HITI is currently unprofitable.

Growing Profit Margin: HITI is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: HITI is unprofitable, and losses have increased over the past 5 years at a rate of 18.6% per year.

Accelerating Growth: Unable to compare HITI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HITI is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-51.1%).

Return on Equity

High ROE: HITI has a negative Return on Equity (-20.87%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 03:22
End of Day Share Price 2024/12/20 00:00
Earnings2024/07/31
Annual Earnings2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

High Tide Inc. is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David KideckelATB Capital Markets
Frederico Yokota Choucair GomesATB Capital Markets
Doug CooperBeacon Securities Limited